BIAS
NVAX icon

Beacon Investment Advisory Services’s Novavax NVAX Stock Holding History

Beacon Investment Advisory Services’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57 Sell
6
-52
-90% -$466 ﹤0.01% 803
2026
Q1 		$473 Buy
+58
New +$526 ﹤0.01% 762

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Beacon Investment Advisory Services's NVAX Position: Q2 2026 in Review

Beacon Investment Advisory Services reduced its Novavax (NVAX) stake by 90% in Q2 2026, selling an estimated $466 and leaving 6 shares worth $57. The position accounts for ﹤0.01% of the portfolio, ranked #803.

Beacon Investment Advisory Services first reported a position in NVAX in Q1 2026 and has held it in 2 quarters since. The position peaked at $473 in Q1 2026. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Beacon Investment Advisory Services held 6 shares of Novavax worth $57 as of Q2 2026.
  • Beacon Investment Advisory Services sold 52 Novavax shares in Q2 2026, an estimated $466.
  • Novavax made up ﹤0.01% of Beacon Investment Advisory Services's portfolio in Q2 2026, its #803 holding.
  • Beacon Investment Advisory Services first reported a position in Novavax in Q1 2026 and has held it in 2 quarters since.
  • Beacon Investment Advisory Services's Novavax position peaked at $473 in Q1 2026.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.